Our site uses cookies to offer a better navigation functionality, including "third party" cookies and "profiling cookies" designed to send on-line commercial communications in line with the preferences expressed by the user while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here to disable them. Upon proceeding with browsing this website, you will be consenting to the use of cookies.

Latest News

Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today that both companies have entered into a global l...
The Menarini Group has consolidated its presence in Latin America with new affiliates in Colombia and Peru. Both countries have emerging economies ...
READ ALL NEWS »
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24

Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24

Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today that both companies have entered into a global license agreement for SEL24, a dual PIM/FLT3 inhibitor currently in Phase I/II trials in acute myeloid leukemia (AML) patients.

Trisome Games 2016

“Noi di Menarini siamo particolarmente attenti e sensibili a tutte le attività che  rispondono alle esigenze sociali e che coinvolgono anche gli sportivi. Ci ha colpito molto positivamente questa iniziativa, che vedrà gareggiare atleti speciali, provenienti da tutto il mondo. Essere poi Sponsor di una manifestazione internazionale alla sua prima edizione, e quindi per un certo verso storica, non può che renderci entusiasti.” commenta così Ennio 
Troiano, Direttore Risorse Umane del Gruppo Menarini.

Scopri di più

Quality first

 
 

Quality: point of departure and arrival for our drugs.

READ MORE »